Patient Guide to Support Services

2019 Patient Guide to Support Services

Boehringer Ingelheim’s Gilotrif Patient Services includes a range of programs and services offered through the company’s Solutions Plus program. This program provides support, education, and reimbursement services to patients who are prescribed Gilotrif (afatinib), as well as to their providers. Read More ›

Through its Access Support program, Bristol-Myers Squibb (BMS) offers a variety of oncology support options for patients receiving outpatient treatment in the United States and Puerto Rico. Read More ›

Celgene Corporation offers patient support services for patients receiving Celgene medications through the Celgene Patient Support program. This program offers eligible patients a range of support services to access Celgene’s oncology drugs, regardless of their insurance status. Read More ›

Clovis Oncology’s Rubraca Connections is a comprehensive patient support services program designed to help patients who are prescribed Rubraca (rucaparib) tablets. This includes coordinating ­Rubraca delivery and pick-up, finding financial support programs, and connecting patients with a specialty pharmacy team. Read More ›

Coherus BioSciences’ Coherus COMPLETE offers comprehensive reimbursement and patient support services for patients receiving treatment with Udenyca (pegfilgrastim-cbqv) who are unable to afford the medication, along with provider service programs to help access Udenyca and secure patient reimbursements. Read More ›

Amgen Assist 360 provides several support services for insured, uninsured, and underinsured patients who encounter financial hardships and cannot afford the Amgen medications they are prescribed, including Amgen FIRST STEP and the Amgen Safety Net Foundation. Read More ›

Eisai Reimbursement Resources is a program designed to offer drug-specific assistance related to the coding, coverage, and reimbursement of select Eisai drugs, as well as a variety of patient assistance services for patients who are prescribed Eisai’s drugs and who are having difficulty paying for the cost of their care. Read More ›

EMD Serono and Pfizer provide the CoverOne program, a patient assistance program that offers reimbursement services, copay assistance, and billing and coding resources for patients who are prescribed Bavencio (avelumab), a fully human anti–PD-L1 monoclonal antibody. Read More ›

Exelixis Access Services (EASE) includes a set of personalized support programs that offer a full range of services designed to support healthcare providers and patients who are prescribed Cabometyx (cabozantinib) or Cometriq (cabozantinib). Read More ›

Genentech Access Solutions offers a suite of programs and services to help facilitate access to Genentech BioOncology medicines for eligible patients. Support services include coverage and reimbursement assistance, financial assistance, and resource support. Read More ›

Gilead Sciences Zydelig AccessConnect is a patient support program that offers ease of access and financial support for patients receiving treatment with Zydelig (idela­lisib) who are unable to afford the medication. Read More ›

Helsinn Therapeutics offers the Helsinn Cares program that supports access, reimbursement, and assistance for patients who are prescribed Akynzeo (netupitant and palonosetron) or Valchlor (mechlor­ethamine gel). Akynzeo is indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV). Valchlor is indicated for the topical treatment of stage IA/IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received skin-directed therapy. Read More ›

Heron Therapeutics’s Heron Connect offers comprehensive support and access services for patients who have been prescribed Sustol (granisetron) extended-release injection and/or Cinvanti (aprepitant) injectable emulsion. Read More ›

IncyteCARES (Connecting to Access, Reimbursement, Education, and Support) provides a single point of contact through a registered nurse to assist eligible patients and healthcare providers in obtaining access to Jakafi (ruxolitinib) and to connect them with continuing support and resources. Read More ›

Ipsen Biopharmaceuticals provides several patient support services through its IPSEN CARES (Coverage, Access, Reimbursement, & Education Support) program to patients who are prescribed Onivyde (irinotecan liposome injection) or Soma-tuline Depot (lanreotide) injection. Read More ›

Page 3 of 3

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to recieve the free OPM print publications or weekly e‑Newsletter.

I'd like to recieve: